Senior Scientific and Weill Cornell Medicine to Pursue Non-Invasive Prostate Cancer Detection
Manhattan Scientifics, Inc. announced that its wholly-owned subsidiary Senior Scientific, LLC, has established a research collaboration with Weill Cornell Medicine. For the alliance, the company will bring its magnetic relaxometry technology to Weill Cornell Medicine, where scientists will investigate the use of molecularly targeted nanoparticles to non-invasively detect and diagnose prostate cancers. [Manhattan Scientifics, Inc.] Press Release